Latest Regulatory Approval News

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

Chalice Mining reports a robust cash position of approximately $90 million and no debt as it progresses the Gonneville Project towards a targeted Final Investment Decision in 2027. The appointment of Dan Brearley as COO signals strengthened operational leadership amid ongoing metallurgical testwork and exploration activities.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.

NuEnergy has finalized the Gas Sales and Purchase Agreement for its Tanjung Enim project and is advancing drilling preparations, marking a key step toward production and revenue generation.

BPH Energy Limited's December 2024 quarterly report reveals strategic capital placements and investments in hydrogen and medical technology, alongside ongoing regulatory challenges with the PEP-11 permit.

Patagonia Lithium Ltd has announced a maiden JORC Inferred Mineral Resource Estimate of 3.8 million tonnes of Lithium Carbonate Equivalent at its Formentera Lithium Brine Project in Argentina, highlighting significant potential for resource upgrades through ongoing drilling and advanced extraction technology.

Star Minerals secures shareholder approval for its Cobra Uranium Project in Namibia and prepares for maiden drilling, while progressing gold exploration in Western Australia amid a modest capital raise.

Island Pharmaceuticals has enrolled all subjects in the Phase 2b arm of its ISLA-101 dengue fever clinical trial, advancing its antiviral drug development with key results expected in 2025.

Element 25 Limited has announced a 107% increase in Ore Reserves at its Butcherbird Manganese Project in Western Australia, now supporting an 18.3-year mine life at 1.1Mtpa production. This milestone underpins the company’s strategic expansion into battery-grade manganese supply for the EV market.